TY  - GEN
AU  - Pönisch,Wolfram
AU  - Rozanski,Marta
AU  - Goldschmidt,Hartmut
AU  - Hoffmann,Franz Albert
AU  - Boldt,Thomas
AU  - Schwarzer,Andreas
AU  - Ritter,Ute
AU  - Rohrberg,Robert
AU  - Schwalbe,Elke
AU  - Uhlig,Jens
AU  - Zehrfeld,Thomas
AU  - Schirmer,Veronika
AU  - Haas,Antje
AU  - Kreibich,Ute
AU  - Niederwieser,Dietger
TI  - Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial
SN  - 1365-2141
PY  - 2008///1217
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bendamustine Hydrochloride
KW  - Combined Modality Therapy
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Nitrogen Mustard Compounds
KW  - administration & dosage
KW  - Prednisolone
KW  - Recurrence
KW  - Statistics, Nonparametric
KW  - Stem Cell Transplantation
KW  - methods
KW  - Survival Rate
KW  - Thalidomide
KW  - Transplantation, Autologous
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1111/j.1365-2141.2008.07076.x
ER  -